Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" CEP135 "CEP4, FLJ13621, KIAA0635" ENSG00000174799 "Centrosomal protein 135" Q66GS9 4 55948871-56033363 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 27.1" "Cell type enhanced" "Detected in all" 6 "Early spermatids: 56.2;monocytes: 85.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA073950 Uncertain "Focal adhesion sites" NA NA "Focal adhesion sites" "HPA073950: " "unprognostic (2.75e-1)" "unprognostic (2.71e-2)" "unprognostic (2.48e-2)" "unprognostic (1.06e-2)" "unprognostic (3.63e-1)" "unprognostic (3.42e-2)" "unprognostic (4.65e-3)" "unprognostic (4.78e-3)" "unprognostic (1.83e-3)" "unprognostic (9.89e-3)" "unprognostic (9.50e-2)" "unprognostic (2.27e-1)" "unprognostic (6.02e-9)" "unprognostic (7.55e-2)" "unprognostic (5.54e-2)" "unprognostic (1.95e-1)" "prognostic favorable (6.11e-5)" 5.5 3.0 2.9 13.8 6.0 12.8 5.2 5.1 5.3 8.5 4.6 3.1 7.5 4.3 12.8 4.5 4.7 7.4 4.5 3.4 5.3 3.4 5.7 2.9 7.0 13.0 5.8 3.9 9.6 4.5 4.1 6.9 8.1 4.5 4.4 4.6 2.5 3.7 5.9 2.3 5.4 6.2 7.1 5.5 11.1 3.6 9.3 4.6 27.1 5.0 4.5 10.1 4.8 5.6 9.2 8.7 11.9 4.4 7.1 7.5 2.0 6.9 3.8 10.7 10.0 2.2 4.3 4.6 6.9 4.9 6.4 7.5 4.3 7.3 18.9 5.3 3.1 5.1 3.3 11.1 4.3 12.1 5.1 7.1 6.6 5.7 3.8 2.4 11.9 10.4 3.3 3.4 8.0 5.8 2.9 5.3 9.7 12.1 9.1 6.5 4.2 16.6 7.4 6.7 3.5 4.2 12.1 5.1 3.9 4.6 5.2 7.7 8.1 6.2 4.2 5.1 6.7 5.7 7.7 5.2 8.7 14.2 10.3 12.1 5.0 3.5 12.9 4.4 9.4 10.6 11.9 3.4 4.2 4.7 4.1 4.3 4.6 6.0 4.5 2.1 9.2 7.5 4.8 7.0 7.1 4.4 8.7 3.7 2.0 2.9 6.0 5.1 5.3 5.3 3.4 5.8 3.9 4.5 4.6 6.0 14.3 15.9 7.2 8.0 12.6 7.3 2.5 22.7 14.8 7.0 9.8 15.3 3.3 7.8 56.2 15.3 3.9 23.3 4.7 11.7 5.9 4.3 13.9 1.8 9.0 25.4 5.2 12.3 9.2 11.4 5.5 17.8 5.0 85.6 4.3 4.7 11.0 5.7 7.8 9.0 21.0 6.5 6.6 53.2 43.8 5.8 8.0 16.0 5.2 5.5 CPAMD8 "K-CAP, KIAA1283, VIP" ENSG00000160111 "C3 and PZP like, alpha-2-macroglobulin domain containing 8" Q8IZJ3 19 16892947-17026815 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 19.3;retina: 23.7;seminal vesicle: 30.5" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 21.4;Collecting duct cells: 26.2;Glandular cells: 18.0;Leydig cells: 29.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "classical monocyte: 1.5" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "BEWO: 14.7;EFO-21: 9.5;T-47d: 25.8" "Not detected" "Not detected" "HPA031327, HPA031328, HPA031329, HPA031330" Uncertain Uncertain "Focal adhesion sites" "Secreted to blood" NA NA 180000 "Focal adhesion sites" "HPA031327: AB_2673829, HPA031328: AB_2673830, HPA031329: , HPA031330: AB_10603788" "unprognostic (4.71e-3)" "unprognostic (1.07e-2)" "unprognostic (4.20e-2)" "unprognostic (2.76e-2)" "unprognostic (4.32e-2)" "unprognostic (4.06e-3)" "unprognostic (7.85e-2)" "unprognostic (9.30e-2)" "unprognostic (1.58e-1)" "unprognostic (2.71e-2)" "unprognostic (1.62e-1)" "unprognostic (4.24e-2)" "unprognostic (8.69e-2)" "unprognostic (1.01e-3)" "unprognostic (2.08e-1)" "unprognostic (8.45e-2)" "unprognostic (1.80e-2)" 3.1 1.3 1.0 0.4 2.3 0.2 3.6 0.6 2.3 5.3 0.4 2.9 6.5 0.2 1.5 8.2 0.6 0.6 0.4 7.0 1.2 1.3 8.9 0.5 11.5 1.5 4.9 0.4 0.6 0.4 3.5 2.0 3.1 5.1 19.3 0.0 23.7 1.1 30.5 1.7 0.4 0.4 0.4 5.6 1.1 0.1 0.9 2.8 0.9 11.6 1.4 0.4 1.2 1.4 0.2 0.0 0.6 1.5 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 14.7 0.0 0.1 0.0 0.0 0.0 0.0 0.3 9.5 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 2.2 0.5 0.0 0.0 1.4 0.0 0.1 0.4 2.0 0.0 0.0 0.0 0.4 0.0 0.1 25.8 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.6 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.0 2.3 0.6 2.3 1.2 1.3 4.9 0.4 5.1 2.8 20.8 21.4 0.0 10.1 0.8 0.4 4.8 2.5 1.4 12.5 26.2 0.0 6.4 0.0 0.6 1.5 8.6 0.0 0.0 0.0 5.0 2.4 18.0 2.3 0.0 2.6 0.0 0.0 12.9 6.6 3.6 29.1 1.5 0.0 0.0 0.4 0.0 0.9 0.8 6.0 0.0 0.0 0.0 2.8 5.4 1.0 0.5 5.0 0.0 0.0 3.4 FABP3 "FABP11, H-FABP, MDGI, O-FABP" ENSG00000121769 "Fatty acid binding protein 3" P05413 1 31365625-31376850 "Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "heart muscle: 420.9;skeletal muscle: 129.4" "Cell type enriched" "Detected in many" 6 "Cardiomyocytes: 2447.6" "Cancer enhanced" "Detected in all" "renal cancer: 92.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "ASC TERT1: 120.7" "Low region specificity" "Detected in all" "CAB017830, HPA055754" Enhanced Uncertain "Golgi apparatus,Plasma membrane,Focal adhesion sites" NA NA 1640000 4400000 "Focal adhesion sites" "Golgi apparatus, Plasma membrane" "CAB017830: , HPA055754: AB_2682909" "unprognostic (2.07e-2)" "unprognostic (2.50e-2)" "unprognostic (1.32e-3)" "unprognostic (1.73e-2)" "unprognostic (2.05e-1)" "unprognostic (1.62e-1)" "unprognostic (6.07e-3)" "unprognostic (1.04e-1)" "unprognostic (6.86e-2)" "unprognostic (1.18e-1)" "unprognostic (2.85e-1)" "unprognostic (1.67e-1)" "prognostic favorable (1.54e-7)" "unprognostic (5.80e-3)" "unprognostic (3.45e-1)" "unprognostic (7.38e-3)" "unprognostic (9.76e-3)" 2.3 5.2 8.1 0.7 6.0 0.5 22.7 1.4 14.6 3.9 1.3 0.8 3.4 0.7 6.8 5.3 3.1 2.8 1.1 420.9 11.0 5.3 21.3 1.9 4.3 1.3 9.8 6.0 2.2 0.4 0.3 0.7 1.1 13.7 5.0 1.5 3.0 4.4 14.0 129.4 0.9 0.6 13.0 3.4 3.9 3.6 2.0 1.3 0.1 1.7 31.6 2.2 2.5 2.5 1.4 0.5 0.0 0.9 0.2 0.9 0.6 0.1 0.0 3.3 0.2 23.1 120.7 1.1 0.9 8.9 0.1 3.2 0.2 0.9 0.2 12.8 2.5 0.0 0.3 0.9 0.0 0.1 0.1 0.5 0.4 1.1 2.4 1.5 0.2 0.0 10.7 0.0 2.4 0.0 0.3 0.0 0.1 0.2 0.0 1.1 0.0 0.0 0.2 6.1 0.0 0.4 0.1 1.2 0.0 2.9 0.0 0.3 0.0 0.5 0.0 13.9 7.1 0.1 1.4 0.3 0.2 0.1 2.1 0.2 0.1 0.4 0.1 0.5 0.1 0.3 0.0 0.4 0.0 0.9 0.9 0.6 0.2 0.5 0.5 0.5 1.4 0.0 0.9 0.0 0.2 0.1 0.4 0.6 0.6 8.1 6.0 1.4 13.3 11.0 5.3 9.8 6.0 13.7 1.3 0.0 1.7 0.8 1.0 3.2 3.1 2447.6 5.1 2.7 2.3 26.2 2.0 2.1 383.0 0.3 2.1 0.8 0.0 0.0 0.3 1.3 14.9 3.8 1.1 0.0 96.1 7.9 0.0 3.7 20.0 4.2 6.4 17.6 8.5 0.0 0.0 2.7 0.5 3.6 7.4 399.5 8.1 0.0 32.3 0.3 0.1 2.6 1.4 1.0 0.1 5.2 FBXO28 "CENP-30, Fbx28, FLJ10766, KIAA0483" ENSG00000143756 "F-box protein 28" Q9NVF7 1 224114087-224162047 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003289 Supported "Nucleoplasm,Focal adhesion sites" NA NA Nucleoplasm "Focal adhesion sites" "HPA003289: AB_2666879" "unprognostic (4.91e-2)" "unprognostic (5.57e-2)" "unprognostic (1.78e-2)" "unprognostic (1.03e-1)" "unprognostic (1.33e-2)" "unprognostic (1.43e-1)" "unprognostic (2.12e-1)" "unprognostic (8.25e-2)" "unprognostic (2.03e-1)" "unprognostic (7.09e-2)" "unprognostic (5.09e-3)" "unprognostic (2.60e-1)" "unprognostic (1.98e-3)" "unprognostic (9.46e-2)" "unprognostic (1.71e-1)" "unprognostic (1.41e-1)" "unprognostic (2.61e-1)" 17.4 13.1 16.4 14.9 19.7 12.1 19.6 22.5 21.6 18.7 15.9 15.0 13.1 13.3 16.2 13.3 22.2 14.1 15.1 15.0 15.3 15.6 21.4 26.6 14.0 14.9 15.9 13.6 18.7 13.4 25.7 16.2 15.8 20.2 16.5 17.1 11.9 16.6 14.9 24.6 32.3 14.4 15.7 15.6 16.1 13.7 11.9 15.5 19.4 15.7 13.1 16.1 17.5 20.0 10.3 10.0 14.7 8.9 10.9 11.0 5.7 14.1 6.3 9.8 10.4 10.3 11.8 16.1 14.3 11.7 9.7 9.3 8.6 11.1 6.8 14.8 13.0 6.2 12.5 14.4 13.9 16.8 9.6 16.1 8.6 7.9 6.2 12.8 16.3 11.4 11.5 16.8 14.0 25.6 11.4 16.1 8.9 14.1 9.8 17.4 4.6 8.4 8.3 23.3 18.8 13.5 9.0 14.0 12.8 18.3 9.4 15.9 17.0 14.9 22.9 15.9 10.7 12.1 16.4 18.4 12.1 9.2 15.1 26.9 10.7 12.6 10.7 15.0 8.0 23.4 8.9 8.7 14.7 7.8 8.1 10.1 10.3 8.2 9.6 10.0 10.2 8.3 9.1 5.3 10.9 8.9 4.7 11.0 5.7 16.4 19.7 22.5 21.6 15.3 15.6 15.9 13.6 20.2 15.5 6.0 8.8 12.3 21.3 30.5 18.7 10.6 7.6 6.7 11.4 10.4 21.6 12.1 8.3 10.9 19.1 14.2 10.6 23.3 9.8 11.5 11.0 18.7 13.9 22.2 12.3 17.5 17.7 9.8 16.3 11.5 12.0 13.9 27.0 10.8 14.0 10.1 13.4 10.5 12.4 17.9 18.4 12.9 11.3 26.0 26.5 34.3 19.2 17.5 11.9 27.2 LIMS4 LIMS3L ENSG00000256671 "LIM zinc finger domain containing 4" P0CW20 2 110446640-110473075 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in single" 26 "Exocrine glandular cells: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 2.7;HHSteC: 2.5;hTEC/SVTERT24-B: 4.9;HUVEC TERT2: 2.8;U-138 MG: 5.3" HPA058455 Uncertain Uncertain "Focal adhesion sites,Cytosol" NA NA Cytosol "Focal adhesion sites" "HPA058455: AB_2683723" "unprognostic (2.12e-1)" 4.0 4.1 0.0 0.3 0.0 0.6 1.5 0.0 0.3 0.3 0.6 0.3 4.1 0.3 0.3 3.7 0.3 3.5 0.0 0.0 5.5 2.7 0.8 0.3 0.0 1.9 2.2 0.3 0.8 0.6 0.3 0.3 0.3 0.3 5.6 0.4 0.3 0.3 0.0 0.3 0.3 1.3 1.1 0.3 0.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 2.7 0.2 0.7 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 4.9 0.0 0.0 2.8 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.3 0.2 0.0 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 NUP214 "CAIN, CAN, D9S46E, N214" ENSG00000126883 "Nucleoporin 214" P35658 9 131125561-131234670 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 131.5" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 225.7;Kupffer cells: 255.0;Late spermatids: 282.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 43.7;neutrophil: 131.5" "Group enriched" "Detected in many" 5 "granulocytes: 131.5;monocytes: 43.7" "Cell line enhanced" "Detected in all" "K-562: 73.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048789 Approved "Nucleoplasm,Vesicles,Focal adhesion sites" NA NA 100000 Nucleoplasm "Vesicles, Focal adhesion sites" "HPA048789: AB_2680521" "unprognostic (1.30e-1)" "unprognostic (9.51e-3)" "unprognostic (9.92e-3)" "unprognostic (1.15e-1)" "unprognostic (7.42e-2)" "unprognostic (8.31e-2)" "unprognostic (1.07e-3)" "unprognostic (2.10e-2)" "unprognostic (3.35e-1)" "unprognostic (4.95e-1)" "unprognostic (6.60e-3)" "unprognostic (1.08e-1)" "prognostic favorable (2.39e-5)" "unprognostic (5.49e-2)" "unprognostic (6.84e-2)" "unprognostic (1.82e-1)" "unprognostic (1.53e-1)" 16.9 10.3 11.5 13.8 13.9 29.4 12.9 13.0 14.4 10.2 11.4 19.8 10.4 9.0 15.0 13.7 16.1 12.1 10.2 9.7 9.5 8.1 19.0 15.1 11.7 13.3 13.2 8.8 14.2 17.0 16.7 16.9 13.0 11.3 11.1 10.8 15.3 13.0 11.1 15.5 17.5 11.7 11.1 14.3 35.8 12.3 63.7 13.3 27.4 11.8 7.6 16.8 10.7 11.2 1.2 16.8 131.5 43.7 1.2 0.8 17.9 6.8 9.8 8.4 5.0 6.8 6.6 8.8 6.1 6.3 8.0 6.5 8.0 5.0 11.1 4.9 8.4 8.3 15.7 11.3 8.0 7.8 8.0 5.5 6.9 14.0 15.6 6.0 10.8 7.5 7.1 7.4 10.2 8.3 5.1 8.1 7.4 73.0 6.4 8.2 12.8 14.2 16.4 9.1 9.9 8.6 5.0 10.6 11.1 9.2 6.3 7.1 7.4 10.2 9.4 5.3 6.3 12.4 27.0 7.0 14.1 7.9 9.2 9.9 5.6 10.9 10.8 6.9 6.5 8.5 3.5 43.7 17.3 0.7 18.4 0.8 1.2 0.7 0.6 16.8 1.1 0.7 0.7 131.5 1.2 15.0 1.5 0.4 17.9 11.5 13.9 13.0 14.4 9.5 8.1 13.2 8.8 11.3 13.3 17.9 19.9 15.2 9.5 7.7 29.6 24.0 15.3 16.0 15.9 22.7 43.2 10.9 8.3 9.1 225.7 14.6 13.6 0.0 13.1 9.3 11.4 11.4 8.1 11.9 75.5 15.9 19.5 18.4 255.0 282.5 21.6 77.0 10.1 15.4 14.3 14.8 12.0 5.8 19.1 6.7 31.6 6.5 8.1 90.1 44.5 9.5 9.2 11.8 16.3 9.3 PCDHGA2 PCDH-GAMMA-A2 ENSG00000081853 "Protocadherin gamma subfamily A, 2" Q9Y5H1 5 141338760-141512979 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 13 "Bipolar cells: 2.7;Cardiomyocytes: 1.6;Leydig cells: 1.1;Peritubular cells: 2.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 9.8;BJ: 5.4;fHDF/TERT166: 6.3;HSkMC: 5.0;hTERT-RPE1: 5.8" "Low region specificity" "Detected in all" "HPA008755, HPA010580, HPA038625" Approved Approved "Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol" NA NA "Vesicles, Plasma membrane" "Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol" "HPA008755: AB_1079577, HPA010580: AB_2732401, HPA038625: AB_2732480" "unprognostic (2.43e-3)" "unprognostic (2.10e-2)" "unprognostic (1.32e-2)" "unprognostic (4.54e-1)" "unprognostic (2.92e-1)" "unprognostic (1.14e-1)" "unprognostic (3.01e-1)" "unprognostic (2.82e-1)" "unprognostic (1.56e-1)" "unprognostic (1.18e-1)" "unprognostic (9.01e-2)" "unprognostic (4.32e-2)" "unprognostic (8.45e-3)" "unprognostic (9.68e-3)" "unprognostic (1.04e-2)" "unprognostic (1.18e-2)" "unprognostic (2.23e-4)" 5.1 4.3 6.7 2.1 8.0 0.6 4.2 5.2 12.6 6.6 2.6 4.6 1.0 0.9 6.5 5.7 2.4 5.5 5.5 11.1 6.5 4.6 3.3 2.4 4.6 1.1 6.0 2.3 15.3 8.4 9.2 10.6 2.2 7.8 5.3 1.4 13.8 3.3 5.8 2.6 2.9 1.4 5.2 5.6 1.9 2.1 10.4 3.5 0.0 4.3 1.2 1.1 3.2 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.3 3.9 9.8 0.1 5.4 2.1 0.5 0.9 0.1 0.1 0.1 0.7 6.3 0.8 0.2 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 5.0 0.2 0.1 0.3 5.8 2.0 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.1 1.4 0.3 0.2 0.8 0.0 0.3 0.7 0.0 3.6 0.1 0.5 0.7 0.0 3.3 0.9 0.5 0.3 0.1 0.0 0.4 0.0 2.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 8.0 5.2 7.2 6.5 4.6 6.0 2.3 7.8 3.5 0.0 0.0 0.0 0.1 0.0 2.7 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.5 0.3 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 RAB24 ENSG00000169228 "RAB24, member RAS oncogene family" Q969Q5 5 177301198-177303744 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 55.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034945 Uncertain "Focal adhesion sites" No No "Focal adhesion sites" "HPA034945: " "unprognostic (1.03e-2)" "unprognostic (6.81e-2)" "unprognostic (3.05e-2)" "unprognostic (1.59e-1)" "unprognostic (7.86e-2)" "prognostic favorable (6.22e-4)" "prognostic unfavorable (7.56e-5)" "unprognostic (1.28e-1)" "unprognostic (1.78e-2)" "unprognostic (9.66e-2)" "unprognostic (1.43e-3)" "unprognostic (2.79e-2)" "prognostic unfavorable (2.54e-7)" "unprognostic (3.97e-2)" "unprognostic (1.22e-1)" "unprognostic (2.75e-1)" "unprognostic (1.12e-2)" 13.6 19.7 18.3 19.9 20.9 24.6 16.8 25.0 24.2 12.1 13.7 7.5 25.3 15.3 10.9 23.6 21.0 11.9 12.4 12.7 15.4 18.0 16.6 15.2 14.2 15.5 13.1 22.0 16.9 31.4 16.2 26.0 15.6 19.8 15.3 11.0 14.1 23.2 20.8 27.1 19.5 15.6 14.5 10.6 27.6 12.8 5.7 13.1 5.9 18.8 15.1 19.9 11.0 15.9 7.5 14.5 38.0 42.0 7.9 5.1 10.2 2.9 7.9 5.2 10.4 8.5 7.5 10.9 9.1 11.4 11.3 13.7 9.5 3.9 3.2 11.2 7.2 12.6 2.8 7.0 9.8 6.3 55.2 5.6 11.0 8.0 8.1 17.9 6.9 10.0 12.4 8.0 12.0 8.5 16.7 6.9 8.8 8.2 17.5 7.9 11.2 2.5 19.9 3.3 5.9 8.0 1.5 8.6 12.4 7.6 5.2 6.7 9.1 2.8 5.6 23.5 6.6 10.1 17.4 7.6 4.0 6.5 9.1 7.8 13.4 6.3 4.1 7.5 11.2 8.4 8.7 21.4 38.0 5.1 42.0 4.4 7.5 2.5 4.2 14.5 6.8 2.8 4.4 33.0 7.9 40.7 3.2 2.1 10.2 18.3 20.9 25.0 24.2 15.4 18.0 13.1 22.0 19.8 13.1 3.0 10.3 9.9 1.7 4.7 3.1 2.0 0.0 4.0 10.3 1.8 2.0 6.2 3.3 21.3 0.3 4.2 15.7 0.0 17.6 4.6 4.4 1.9 11.5 1.5 3.9 12.7 17.3 8.0 10.0 0.2 4.6 9.1 3.3 1.0 12.6 1.9 16.4 15.2 1.1 5.4 4.4 0.0 4.1 2.4 3.3 5.3 25.6 4.9 12.8 2.0 SNX32 "FLJ30934, SNX6B" ENSG00000172803 "Sorting nexin 32" Q86XE0 11 65833641-65856896 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 16.6" "Cell type enhanced" "Detected in some" 12 "Early spermatids: 10.4;Late spermatids: 8.2;Spermatocytes: 4.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 1.0;dendritic cells: 1.2;T-cells: 3.0" "Cell line enhanced" "Detected in some" "HHSteC: 6.1;HSkMC: 8.0;REH: 2.6;SH-SY5Y: 3.1;U-266/70: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041775 Uncertain Uncertain "Cell Junctions,Focal adhesion sites" NA NA "Cell Junctions, Focal adhesion sites" "HPA041775: AB_10797268" "unprognostic (6.74e-4)" "unprognostic (1.06e-1)" "unprognostic (1.67e-2)" "unprognostic (4.50e-5)" "unprognostic (1.00e-1)" "unprognostic (9.28e-2)" "unprognostic (7.30e-2)" "unprognostic (9.17e-3)" "unprognostic (2.70e-1)" "unprognostic (2.87e-1)" "unprognostic (5.08e-2)" "unprognostic (1.52e-1)" "unprognostic (3.64e-4)" "unprognostic (2.14e-1)" "unprognostic (1.14e-1)" "unprognostic (9.80e-2)" "unprognostic (5.36e-2)" 0.8 1.0 9.0 1.1 16.6 1.3 1.3 3.5 16.1 1.6 2.2 1.6 0.0 3.4 2.0 1.3 0.9 2.5 2.8 0.9 10.2 5.0 0.9 0.7 0.8 1.0 3.6 10.9 1.3 0.8 0.8 0.3 0.9 3.4 0.8 1.9 0.1 0.7 0.9 0.6 1.1 1.5 2.0 1.8 0.9 0.9 3.5 3.7 0.0 0.7 0.0 1.3 1.0 0.2 1.0 1.2 0.2 0.3 0.1 3.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.1 0.0 0.7 8.0 0.1 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.4 0.0 0.5 0.3 0.1 0.0 0.0 2.6 0.0 2.3 0.1 0.0 0.0 3.1 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 9.3 1.6 0.0 0.7 0.0 0.3 0.0 0.1 0.0 1.2 0.3 3.0 0.3 1.6 1.2 1.2 1.0 1.4 0.6 0.2 0.1 0.0 0.7 1.2 0.4 9.0 16.6 3.5 15.4 10.2 5.0 3.6 10.9 3.4 3.7 0.0 1.1 0.0 0.3 0.3 1.7 0.8 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 10.4 0.5 0.8 0.0 0.0 0.1 0.6 0.1 3.5 0.0 0.3 0.0 0.0 0.6 0.0 8.2 0.3 0.0 1.7 0.0 0.3 0.8 0.1 0.0 1.1 0.2 0.5 0.0 0.3 4.4 1.3 0.4 0.0 0.0 1.2 0.1 TMEM35A "FLJ14084, TMEM35" ENSG00000126950 "Transmembrane protein 35A" Q53FP2 X 101078720-101096364 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.8;seminal vesicle: 46.4" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 6.5;HUVEC TERT2: 32.3;SH-SY5Y: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048583 Enhanced Supported Supported "Vesicles,Focal adhesion sites,Cytosol" NA NA Vesicles "Focal adhesion sites, Cytosol" "HPA048583: AB_2680451" "unprognostic (7.98e-2)" "unprognostic (7.22e-2)" "unprognostic (1.21e-2)" "unprognostic (1.35e-2)" "unprognostic (3.02e-2)" "unprognostic (3.89e-3)" "unprognostic (2.77e-2)" "unprognostic (6.66e-3)" "unprognostic (1.05e-1)" "unprognostic (3.34e-3)" "unprognostic (9.20e-2)" "unprognostic (4.72e-2)" "unprognostic (3.49e-4)" "unprognostic (5.91e-2)" "unprognostic (1.85e-1)" "unprognostic (1.48e-2)" "unprognostic (9.37e-3)" 3.6 6.7 12.8 1.7 28.2 0.7 1.3 21.2 28.6 3.3 17.3 2.5 6.8 3.5 7.4 3.9 10.4 4.3 3.6 1.1 14.4 33.8 1.1 0.7 2.6 0.8 12.2 10.0 7.7 0.9 6.1 1.5 0.8 30.0 20.5 9.1 2.9 1.0 46.4 1.3 0.9 4.1 11.8 3.9 1.3 3.4 1.8 2.3 0.0 1.3 0.0 0.9 13.3 2.7 0.2 0.0 0.2 0.1 0.6 0.8 0.4 0.0 0.0 3.4 0.0 2.5 6.5 0.0 0.6 0.4 0.3 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 2.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 2.2 0.0 1.1 0.0 4.7 32.3 0.0 0.0 0.0 4.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 8.3 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.5 0.2 0.5 0.2 0.0 0.0 0.6 0.4 0.2 0.6 0.1 0.0 0.8 0.4 12.8 28.2 21.2 28.6 14.4 33.8 12.2 10.0 30.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TNNT2 "CMD1D, CMH2, CMPD2" ENSG00000118194 "Troponin T2, cardiac type" P45379 1 201359008-201377762 "Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins" "Muscle protein" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 241 "heart muscle: 679.2" "Cell type enriched" "Detected in many" 289 "Cardiomyocytes: 11884.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 18 "RH-30: 189.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB015371, HPA015774, HPA017888" Enhanced Uncertain "Nucleoplasm,Nucleoli,Focal adhesion sites" No No 50000 "Nucleoplasm, Nucleoli" "Focal adhesion sites" "CAB015371: AB_630390, HPA015774: AB_1858354, HPA017888: AB_1858355" "unprognostic (1.45e-1)" "unprognostic (2.74e-1)" "unprognostic (2.33e-4)" "unprognostic (1.85e-1)" "unprognostic (7.29e-2)" "unprognostic (1.79e-1)" "unprognostic (1.80e-1)" "unprognostic (1.24e-1)" "unprognostic (1.42e-1)" "unprognostic (2.91e-2)" "unprognostic (1.38e-1)" "unprognostic (8.63e-2)" "unprognostic (5.50e-3)" "unprognostic (2.94e-1)" "unprognostic (1.61e-1)" "unprognostic (4.76e-2)" "unprognostic (9.98e-2)" 0.1 0.3 0.1 0.1 0.7 0.0 0.8 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.2 679.2 0.9 0.0 1.9 0.0 0.7 0.3 0.1 1.1 0.1 0.3 0.0 0.2 0.7 0.1 0.7 0.0 0.0 0.2 0.1 2.0 1.3 0.0 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.1 0.0 0.0 0.4 0.5 0.0 0.0 189.8 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 10.5 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 2.1 0.9 0.0 0.1 1.1 0.1 0.0 3.0 4.0 0.0 1.1 3.1 1.0 11884.8 0.0 0.0 1.2 1.8 0.0 2.3 0.0 0.5 9.4 0.0 1.6 0.0 0.3 0.9 41.1 0.5 0.0 0.0 2.7 0.0 0.0 0.0 0.0 13.6 0.6 0.0 0.0 4.6 0.5 0.0 0.7 0.8 1.1 0.8 0.5 0.0 0.4 0.0 0.2 6.4 3.5 0.0 2.8 1.4 TRPC7 ENSG00000069018 "Transient receptor potential cation channel subfamily C member 7" Q9HCX4 5 136213320-136365545 "Predicted membrane proteins, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 2.2;brain: 1.6;intestine: 1.3;kidney: 1.5;pituitary gland: 2.2;testis: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.8;SCLC-21H: 1.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB022592, HPA031126" Uncertain Uncertain "Actin filaments,Focal adhesion sites" NA NA "Focal adhesion sites" "Actin filaments" "CAB022592: , HPA031126: AB_10603221" "unprognostic (1.49e-1)" "unprognostic (2.08e-1)" "unprognostic (3.03e-2)" "unprognostic (2.89e-5)" "unprognostic (3.26e-1)" "unprognostic (2.75e-1)" "unprognostic (9.99e-2)" "unprognostic (1.77e-1)" "unprognostic (6.78e-2)" 0.0 2.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 USP40 FLJ10785 ENSG00000085982 "Ubiquitin specific peptidase 40" Q9NVE5 2 233475520-233566782 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005821 Uncertain Approved "Vesicles,Focal adhesion sites" NA NA Vesicles "Focal adhesion sites" "HPA005821: AB_1080526" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (1.13e-1)" "unprognostic (1.33e-1)" "unprognostic (3.70e-1)" "unprognostic (2.15e-1)" "unprognostic (5.30e-2)" "unprognostic (2.25e-1)" "unprognostic (1.80e-2)" "unprognostic (1.18e-1)" "unprognostic (1.96e-1)" "unprognostic (1.26e-1)" "unprognostic (2.22e-1)" "unprognostic (1.45e-1)" "unprognostic (4.09e-2)" "unprognostic (1.90e-2)" "unprognostic (2.53e-2)" 12.5 20.5 11.0 8.2 17.7 3.5 16.1 8.2 13.5 12.4 12.1 26.1 22.5 11.6 16.2 28.1 13.9 13.4 13.2 10.8 11.3 8.5 16.9 15.7 13.9 7.6 22.1 10.1 19.6 17.2 22.8 24.3 16.3 16.5 16.1 11.2 16.4 13.9 19.7 13.6 21.7 15.2 17.1 20.1 11.4 16.3 23.3 18.9 9.8 21.2 9.4 12.0 18.0 11.8 1.9 5.0 0.4 2.8 1.4 2.2 1.4 9.5 11.1 10.2 6.9 15.0 14.1 9.0 9.4 7.3 8.8 9.6 7.9 11.4 0.2 2.8 15.1 22.6 17.0 7.8 16.7 12.6 0.0 5.1 7.5 9.2 13.3 13.1 3.1 5.1 13.4 12.1 12.9 18.2 15.4 10.1 4.6 12.1 1.8 12.3 7.7 3.4 4.7 4.5 9.9 9.0 0.0 21.2 4.4 10.4 15.4 5.6 6.1 7.5 7.8 9.7 8.0 8.8 7.1 9.9 12.2 7.6 5.1 11.4 3.4 2.6 0.4 15.9 5.7 10.6 0.0 2.7 0.0 1.3 2.8 0.6 1.3 1.5 1.3 4.0 1.9 1.9 2.2 0.4 1.4 2.3 5.0 2.0 1.4 11.0 17.7 8.2 13.5 11.3 8.5 22.1 10.1 16.5 18.9 29.8 31.5 3.7 9.6 6.5 18.6 8.9 10.2 24.1 23.9 15.7 23.6 17.1 6.6 7.9 6.7 7.1 10.9 0.0 10.6 8.8 7.4 11.3 9.2 20.9 7.0 22.3 14.5 12.3 10.4 7.8 6.4 6.7 3.3 5.4 9.1 13.0 9.7 8.6 7.8 11.6 20.8 12.9 8.2 31.2 14.9 9.3 13.2 4.4 11.2 7.1